1. Home
  2. RAIL vs ENTA Comparison

RAIL vs ENTA Comparison

Compare RAIL & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAIL
  • ENTA
  • Stock Information
  • Founded
  • RAIL 1901
  • ENTA 1995
  • Country
  • RAIL United States
  • ENTA United States
  • Employees
  • RAIL N/A
  • ENTA N/A
  • Industry
  • RAIL Railroads
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAIL Industrials
  • ENTA Health Care
  • Exchange
  • RAIL Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • RAIL 187.4M
  • ENTA 164.6M
  • IPO Year
  • RAIL N/A
  • ENTA 2013
  • Fundamental
  • Price
  • RAIL $8.58
  • ENTA $8.00
  • Analyst Decision
  • RAIL
  • ENTA Strong Buy
  • Analyst Count
  • RAIL 0
  • ENTA 4
  • Target Price
  • RAIL N/A
  • ENTA $20.75
  • AVG Volume (30 Days)
  • RAIL 225.4K
  • ENTA 172.2K
  • Earning Date
  • RAIL 08-04-2025
  • ENTA 08-11-2025
  • Dividend Yield
  • RAIL N/A
  • ENTA N/A
  • EPS Growth
  • RAIL N/A
  • ENTA N/A
  • EPS
  • RAIL N/A
  • ENTA N/A
  • Revenue
  • RAIL $465,864,000.00
  • ENTA $64,806,000.00
  • Revenue This Year
  • RAIL $2.93
  • ENTA N/A
  • Revenue Next Year
  • RAIL $5.83
  • ENTA $4.05
  • P/E Ratio
  • RAIL N/A
  • ENTA N/A
  • Revenue Growth
  • RAIL N/A
  • ENTA N/A
  • 52 Week Low
  • RAIL $4.31
  • ENTA $4.09
  • 52 Week High
  • RAIL $16.10
  • ENTA $13.43
  • Technical
  • Relative Strength Index (RSI)
  • RAIL 35.83
  • ENTA 59.48
  • Support Level
  • RAIL $8.77
  • ENTA $6.45
  • Resistance Level
  • RAIL $9.54
  • ENTA $7.73
  • Average True Range (ATR)
  • RAIL 0.59
  • ENTA 0.51
  • MACD
  • RAIL -0.21
  • ENTA 0.05
  • Stochastic Oscillator
  • RAIL 2.84
  • ENTA 83.33

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: